» Articles » PMID: 8254833

Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1994 Jan 1
PMID 8254833
Citations 888
Authors
Affiliations
Soon will be listed here.
Abstract

We provide current, normative data on the prevalence of impotence, and its physiological and psychosocial correlates in a general population using results from the Massachusetts Male Aging Study. The Massachusetts Male Aging Study was a community based, random sample observational survey of noninstitutionalized men 40 to 70 years old conducted from 1987 to 1989 in cities and towns near Boston, Massachusetts. Blood samples, physiological measures, socio-demographic variables, psychological indexes, and information on health status, medications, smoking and lifestyle were collected by trained interviewers in the subject's home. A self-administered sexual activity questionnaire was used to characterize erectile potency. The combined prevalence of minimal, moderate and complete impotence was 52%. The prevalence of complete impotence tripled from 5 to 15% between subject ages 40 and 70 years. Subject age was the variable most strongly associated with impotence. After adjustment for age, a higher probability of impotence was directly correlated with heart disease, hypertension, diabetes, associated medications, and indexes of anger and depression, and inversely correlated with serum dehydroepiandrosterone, high density lipoprotein cholesterol and an index of dominant personality. Cigarette smoking was associated with a greater probability of complete impotence in men with heart disease and hypertension. We conclude that impotence is a major health concern in light of the high prevalence, is strongly associated with age, has multiple determinants, including some risk factors for vascular disease, and may be due partly to modifiable para-aging phenomena.

Citing Articles

Establishing the role of shear wave elastography in differentiating corporal rigidity between vasculogenic versus non-vasculogenic erectile dysfunction patients.

Singh P, Sharma A, Chowhan P, Gorsi U, Mavuduru R, Rehsi S Ultrasound. 2025; :1742271X241275207.

PMID: 40012699 PMC: 11851578. DOI: 10.1177/1742271X241275207.


How to improve functional outcome of inflatable penile implant surgery? a narrative review.

Vural A, De Bruyn H, van Renterghem K Int J Impot Res. 2025; .

PMID: 39966533 DOI: 10.1038/s41443-025-01030-9.


Hormones, Age, and Erectile Dysfunction: Should Routine Testing Be Part of the Initial Evaluation?.

Porav-Hodade D, Gherasim R, Kosovski I, Voidazan T, Crisan N, Bogdan P Diagnostics (Basel). 2025; 15(3).

PMID: 39941224 PMC: 11816566. DOI: 10.3390/diagnostics15030294.


A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004.

Zhang Y, Zang N, Xiang Y, Lin F, Liu X, Zhang J Front Endocrinol (Lausanne). 2025; 15:1412369.

PMID: 39872316 PMC: 11769807. DOI: 10.3389/fendo.2024.1412369.


Determinants of Sexual Dysfunction in Parkinson's Disease Patients: A Secondary Analysis of a Multicenter Cross-Sectional Study.

Manuli A, Maggio M, de Pasquale P, Raciti L, Filoni S, Portaro S J Clin Med. 2025; 14(1.

PMID: 39797235 PMC: 11721904. DOI: 10.3390/jcm14010152.